Intellia Therapeutics, Inc.
NTLA
$9.20
-$0.40-4.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.34% | -34.06% | -23.01% | -23.90% | -15.24% |
| Total Receivables | -71.16% | -76.64% | 36.40% | 143.85% | 642.50% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -34.06% | -37.27% | 36.38% | 103.19% | 123.30% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -37.63% | -35.91% | -20.44% | -19.41% | -8.26% |
|
|
|||||
| Total Current Assets | -37.63% | -35.91% | -20.44% | -19.41% | -8.26% |
| Net Property, Plant & Equipment | 14.46% | 66.52% | -15.39% | -13.44% | -10.87% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 147.75% | -4.03% | 29.93% | 40.65% | 47.06% |
| Total Assets | -21.71% | -8.45% | -5.63% | -9.95% | -11.16% |
|
|
|||||
| Total Accounts Payable | -9.68% | 95.77% | 269.97% | 61.73% | 98.68% |
| Total Accrued Expenses | 3.88% | -7.94% | -14.01% | -13.59% | -12.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 106.59% | 8.86% | 12.32% | 13.21% | 14.91% |
| Total Finance Division Other Current Liabilities | -21.08% | -28.83% | 76.10% | 11.75% | -25.93% |
| Total Other Current Liabilities | -21.08% | -28.83% | 76.10% | 11.75% | -25.93% |
| Total Current Liabilities | 14.99% | -3.78% | 14.93% | 5.25% | -5.29% |
|
|
|||||
| Total Current Liabilities | 14.99% | -3.78% | 14.93% | 5.25% | -5.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.61% | 96.34% | -18.58% | -17.29% | -16.12% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -60.64% | -53.01% | 77.74% | 117.14% | 141.24% |
| Total Liabilities | -7.70% | 27.21% | 2.33% | 0.97% | -1.58% |
|
|
|||||
| Common Stock & APIC | 9.55% | 12.47% | 17.16% | 14.81% | 13.30% |
| Retained Earnings | -29.78% | -31.30% | -34.22% | -36.24% | -37.92% |
| Treasury Stock & Other | 211.62% | 126.79% | 192.30% | 70.14% | 64.64% |
| Total Common Equity | -24.73% | -16.97% | -7.21% | -12.11% | -12.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -24.73% | -16.97% | -7.21% | -12.11% | -12.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -24.73% | -16.97% | -7.21% | -12.11% | -12.99% |
|
|
|||||